Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,607 signal articles · 118 in last 24h · 155,469 total before filter · latest 36m ago
118last 24h
855last 7d
146● bullish (7d)
90● bearish (7d)
214publishers
AllMacro191Earnings105M&A126Regulatory20Product22Analyst19
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
With Bond Market Yields at Multi-Decade Highs, ‘This Is Hit the Wall Stuff’
Barrons.com1d agoneutral
With Bond Market Yields at Multi-Decade Highs, ‘This Is Hit the Wall Stuff’

The bond market awoke from its early autumn slumber this week amid a maelstrom of headlines tied to growth, inflation, and fiscal concerns that dragged Treasury yields to the highest levels in decades and stoked bets on a series of interest-rate hikes from the Federal Reserve. The broader fixed income slump, which was extending into Thursday’s trading session on Wall Street, was largely powered by the renewed surge in global crude prices. “This is ‘hit the wall stuff’ if we continue anything resembling the current pace,” said John Hardy, Saxo’s global head of macro strategy.

Energy Transition Update - Fashion Industry Joins Forces For Renewable Energy Revolution
Simply Wall St.1d agoneutral
Energy Transition Update - Fashion Industry Joins Forces For Renewable Energy Revolution

Levi Strauss & Co. and Marks & Spencer have collaboratively launched the Fashion Renewable Collaborative (FRC) with Schneider Electric, aiming to advance renewable electricity across the fashion industry. Announced during New York Climate Week, this initiative seeks to overcome market barriers hindering suppliers' adoption of renewable energy by offering resources and support for a scalable transition. The FRC provides fashion suppliers with access to education, guidance, and tools such as...

3 Small-Cap Stocks We Find Risky
StockStory1d agoneutral
3 Small-Cap Stocks We Find Risky

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

UnitedHealth: Inside the $942 Million Industry Problem Squeezing Its Margins
TIKR1d agoneutral
UnitedHealth: Inside the $942 Million Industry Problem Squeezing Its Margins

Key TakeawaysUnitedHealth’s commercial segment cost trend ran modestly above 11% in the first half of 2026, with roughly 100 basis points tied to arbitration abuse and provider coding intensity, the same billing dynamic a new Blue Cross Blue Shield Association study says cost insurers $942 million industry wide over two years. Management pushed commercial margin recovery past 2027, a full year later than planned, even as the consolidated medical care ratio improved to 86.

Investing.com1d agobullish
JPMorgan upgrades CoreWeave on stronger compute pricing

Investing.com -- JPMorgan upgraded CoreWeave (NASDAQ: CRWV) to Overweight from Neutral in a note Thursday, telling investors that stronger pricing for computing power and the company's push into short-term contracts at premium rates should lift revenue and margins.

StockStory1d agoneutral
2 Energy Stocks Worth Investigating and 1 We Find Risky

Even if they go mostly unnoticed, energy businesses are the backbone of our country, providing the energy we need to power our lives and businesses.But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates and commodity prices), and the market seems convinced that demand will slow. Due to this bearish outlook, the industry has tumbled by 2.4% over the past six months. This performance is a stark contrast from the S&P 500’s 18.4% gain.

How Micron Stock Could Rise Another 50%
Barrons.com1d agoneutral
How Micron Stock Could Rise Another 50%

Micron Technology stock has plenty left in the tank after its nearly-600% gain in the past 12 months. Micron shares were down 2.4% at $1,046.37 in premarket trading Thursday. UBS’s Arcuri reiterated his target price of $1,625 and a Buy rating on the stock in a research note Wednesday.

3 Financial Stocks Tied Closely To Rising Treasury Yields
Simply Wall St.1d agoneutral
3 Financial Stocks Tied Closely To Rising Treasury Yields

Bond markets are back in the spotlight as the 10 year Treasury pushes above 5%, oil trades over $100, and the Fed leans into renewed rate hikes. That mix is reshaping how risk is priced across equities and credit. Investors who understand which businesses are most exposed to this rate shock, and which might be positioned to handle it, can gain an edge. This article walks through 3 stocks from our fixed income screener that look most directly exposed to this news backdrop and explains how...

Our Pick Of The Best Defense Stocks In September 2026
Simply Wall St.1d agoneutral
Our Pick Of The Best Defense Stocks In September 2026

Global government bond yields are hovering near 4%, a level last seen in 2007, and that shift in borrowing costs is reshaping how investors think about risk and resilience. Aerospace and defense suppliers sit at the intersection of security priorities and long-term government spending, which keeps this corner of the market on many watchlists. This article highlights three stocks from this group that merit a closer look now. The three stocks below are just a sample, and the full screen...

Accenture (ACN) Launches Construct Following A New Question About Whether The Stock Is Fully Valued
Simply Wall St.1d agoneutral
Accenture (ACN) Launches Construct Following A New Question About Whether The Stock Is Fully Valued

Accenture (ACN) just rolled out Accenture Construct, a new global unit focused on planning and delivering large capital projects such as airports, power grids, rail networks and advanced manufacturing facilities. The latest news sits against a mixed share price picture for Accenture, with the stock down 29.4% year to date on a share price basis and the 1-year total shareholder return also falling 20.7%. However, the 90-day share price return has climbed 45.9%, hinting at improving momentum as...

Anglo American (LSE:AAL) Stock Fair Value Rises After Split Analyst Target Changes
Simply Wall St.1d agoneutral
Anglo American (LSE:AAL) Stock Fair Value Rises After Split Analyst Target Changes

Anglo American now sits against a refreshed analyst backdrop, with the central fair value estimate moving from £38.39 to £40.73, an increase of around 6%. That shift reflects recent Street research where some analysts lean into the planned Teck Resources combination and copper exposure, while others keep a tighter focus on cost, freight and execution risks. As you read on, you will see how to interpret these changing targets and follow the evolving narrative around Anglo American. Stay...

What Does Snap (SNAP) Need To Prove As 2,500 Addiction Lawsuits Build?
Simply Wall St.1d agobearish
What Does Snap (SNAP) Need To Prove As 2,500 Addiction Lawsuits Build?

Snap (NYSE: SNAP) faces more than 2,500 federal lawsuits alleging its platforms contribute to social media addiction among minors. Snap, Meta, TikTok, and YouTube reached a landmark settlement with Breathitt County School District, the first multi-platform resolution with a school system. The Breathitt County agreement covers claims that social media products strained district resources by contributing to student mental health and discipline issues. The escalation of addiction lawsuits and...

Cipher Digital (CIFR) Stock Looks Above Fair Value On Sales
Simply Wall St.1d agoneutral
Cipher Digital (CIFR) Stock Looks Above Fair Value On Sales

Cipher Digital has seen its share price move sharply in recent years, so the live question for investors is whether the current US$18.35 price can still be explained by its sales base. The stock has returned roughly 7x over the past 3 years, which puts a lot of weight on whether the underlying revenue profile can carry that kind of re-rating. Fresh headlines around AI focused data centers, Pentagon linked financing discussions and large potential power capacity in Texas may support higher...

Trimble (TRMB) Unveiled Maxwell 8 GNSS Modules With Anti Jamming Protection
Simply Wall St.1d agoneutral
Trimble (TRMB) Unveiled Maxwell 8 GNSS Modules With Anti Jamming Protection

Trimble (NasdaqGS:TRMB) introduced next generation GNSS receiver modules BD1090, BD1092, BD1092i and BX1092i built on Maxwell 8 technology. The new GNSS hardware targets geospatial, construction, marine and mining applications that depend on precise and continuous positioning. Trimble highlighted advanced anti jamming and anti spoofing capabilities aimed at protecting critical positioning services in difficult operating conditions. Trimble's Maxwell 8 GNSS launch for BD1090 and related...

Universal Display (OLED) Stock May Be Underpriced Despite Its 53% Slide
Simply Wall St.1d agoneutral
Universal Display (OLED) Stock May Be Underpriced Despite Its 53% Slide

Universal Display has seen its share price fall sharply over recent years, and that slump puts fresh focus on a simple question for investors. Is the current valuation of the stock still supported by the earnings the business generates today and may deliver in the future? The share price has declined 52.9% over the past 5 years, which puts pressure on the case that Universal Display's earnings outlook can support where the stock trades now. Universal Vapor Jet Corporation's planned NovaJet...

NCCN’s Myeloma MRD Update Spotlighting clonoSEQ Could Be A Game Changer For Adaptive Biotechnologies (ADPT)
Simply Wall St.1d agoneutral
NCCN’s Myeloma MRD Update Spotlighting clonoSEQ Could Be A Game Changer For Adaptive Biotechnologies (ADPT)

Adaptive Biotechnologies recently highlighted updates to the National Comprehensive Cancer Network multiple myeloma guidelines, which now feature a dedicated page on minimal residual disease testing and specifically reference its FDA-cleared clonoSEQ assay with preferred high-sensitivity thresholds and expanded testing timepoints. The inclusion of clonoSEQ by name, alongside broader recommendations for routine and longitudinal MRD assessment, strengthens its position as a standardized tool...